Question 1

In what situations is prophylactic mastectomy appropriate in early-stage breast cancer?

Dr. Jalaj Baxi · Accepted Answer

Only in patients with a genetically determined risk, specifically those who test positive for BRCA1 or BRCA2 mutations. BRCA testing itself is only done when there is a family history of breast cancer.

Question 2

What modalities help prevent reactions to anti-cancer drugs and reduce mortality during chemotherapy?

Dr. Jalaj Baxi · Accepted Answer

Mortality in chemotherapy is a fairly rare event, and when it happens it is almost always due to bone marrow suppression. The key is giving chemotherapy under close supervision so that this suppression is caught early, since early detection is what actually prevents mortality.

Question 3

How does surgery compare with radiotherapy for local control in advanced-stage breast cancer?

Dr. Jalaj Baxi · Accepted Answer

Radiotherapy is used only when surgery is not possible. If chemotherapy shrinks the tumor enough that surgery becomes feasible, surgery should be done. Radiotherapy has very few indications in advanced disease, so a direct comparison between the two is not really meaningful in this setting.

Question 4

What are the natural causes of breast cancer?

Dr. Jalaj Baxi · Accepted Answer

There is no true natural cause; the underlying event is always a gene mutation. About 80% of cases are sporadic mutations with no identifiable cause, while 10 to 15% are genetic or familial. Smoking, alcohol, and tobacco all contribute to mutation risk generally and should be avoided, though this applies to cancer as a whole rather than being specific to breast cancer.

Question 5

On an evolutionary level, how does breast cancer differ between men and women?

Dr. Jalaj Baxi · Accepted Answer

There is no meaningful difference. The same hormone receptors, estrogen, progesterone, and HER2, apply in both male and female breast cancer, and treatment remains the same regardless of sex.

Question 6

Is there a correlation between certain cosmetics, such as talc or lipstick, and the development of breast cancer?

Dr. Jalaj Baxi · Accepted Answer

Various myths and misconceptions exist around this, including the use of talc in the axilla. Some print media point to possible links, but there is no confirmatory or corroborative evidence for a connection between cosmetics and breast cancer.

Question 7

A 65-year-old woman has metastatic breast cancer and mastectomy is not feasible; she is currently on chemotherapy. What chemotherapy regimens are appropriate?

Dr. Jalaj Baxi · Accepted Answer

The regimen depends on the tumor's biology, specifically its ER, PR, and HER2 status. Treatment is usually a combination approach built around anthracycline-based chemotherapy along with hormonal therapy where relevant, and HER2-targeted therapy is added when HER2 is positive. A typical course runs six to eight cycles, though HER2-directed therapy in HER2-positive disease can extend to around 18 to 20 cycles.

Question 8

Can chemotherapy be combined with hormonal therapy, and what other management plans and success rates apply in metastatic disease?

Dr. Jalaj Baxi · Accepted Answer

Yes, combining chemotherapy with hormonal therapy is possible. Further management depends on how the patient responds to treatment. Roughly 30 to 35% of metastatic breast cancer patients respond well, and where the response is strong enough, it can become possible to address the metastatic sites and the primary tumor surgically as well.

Question 9

If a patient remains symptomatic after eight cycles of chemotherapy, what other treatment options are available?

Dr. Jalaj Baxi · Accepted Answer

Immunotherapy can be added, and second-line or third-line chemotherapy regimens are available, including CDK4/6 inhibitors. Next-generation sequencing of the tumor helps identify which newer targeted drugs are likely to be effective for that specific patient.

Question 10

Why do many patients' health seem to deteriorate immediately after a breast cancer diagnosis?

Dr. Jalaj Baxi · Accepted Answer

This is largely psychological rather than driven by the disease itself, a kind of cancer phobia that sets in once the diagnosis is given, where the patient loses a sense of control over their own life and fears dying early or being treated inadequately. Educating patients about their specific disease and realistic treatment outcomes helps restore the sense that there is still a fight to be had, which improves how they cope.

Diagnosis and Management of Breast Cancer

Questions Doctors Asked Dr. Jalaj Baxi